Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial

DSpace Repository

Show simple item record

dc.contributor.author Häring, Hans-Ulrich
dc.date.accessioned 2014-04-01T12:43:41Z
dc.date.available 2014-04-01T12:43:41Z
dc.date.issued 2013
dc.identifier.issn 0149-5992
dc.identifier.uri http://hdl.handle.net/10900/50760
dc.language.iso en de_DE
dc.publisher Amer Diabetes Assoc de_DE
dc.relation.uri http://dx.doi.org/10.2337/dc12-2673 de_DE
dc.rights info:eu-repo/semantics/closedAccess
dc.subject.ddc 610 de_DE
dc.title Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial de_DE
dc.type Artikel de_DE
utue.quellen.id 20140116051827_00306 de_DE
utue.publikation.seiten 3396-3404 de_DE
utue.personen.roh Haering, Hans-Ulrich
utue.personen.roh Merker, Ludwig
utue.personen.roh Seewaldt-Becker, Elke
utue.personen.roh Weimer, Marc
utue.personen.roh Meinicke, Thomas
utue.personen.roh Woerle, Hans J.
utue.personen.roh Broedl, Uli C.
dcterms.isPartOf.ZSTitelID Diabetes Care de_DE
dcterms.isPartOf.ZS-Issue 11 de_DE
dcterms.isPartOf.ZS-Volume 36 de_DE


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record